Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 10/20 | 0.82 |
| ▸ | ACHE | P22303 | 9/20 | 0.82 |
| ▸ | APP | P05067 | 2/20 | 0.82 |
| ▸ | BACE1 | P56817 | 2/20 | 0.82 |
| ▸ | GABRP | O00591 | 1/20 | 0.82 |
| ▸ | GABRD | O14764 | 1/20 | 0.82 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.82 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.82 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.82 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.82 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.82 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.82 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.82 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.82 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.82 |
| ▸ | GABRE | P78334 | 1/20 | 0.82 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.82 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.82 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.82 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8525172 | 0.96 | BCHE (0.85) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL12552080 | 0.95 | BCHE (0.88) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL7674463 | 0.95 | BCHE (0.88) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL13480729 | 0.92 | BCHE (0.92) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL24000133 | 0.92 | BCHE (0.97) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL15168191 | 0.91 | ACHE (1.00) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL29486236 | 0.91 | ACHE (1.00) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL24164216 | 0.91 | ACHE (1.00) | BCHEACHEAPPBACE1GABRP | |
| SCHEMBL12059555 | 0.91 | ACHE (1.00) | BCHEACHEAPPBACE1GABRP | |
| Hydrochloric Acid SCHEMBL29711388 | 0.89 | BCHE (1.00) | BCHEACHEAPPBACE1GABRP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3111941-A1 | COMPOSITIONS COMPRISING CHONDROITIN SULFATE FOR PROPHYLAXIS OR TREATMENT OF DAMAGED ARTICULAR CARTILAGE | Patir, Süleyman (TR) | 2017-01-04 | — | — | EP | claimed |
| US-9016221-B2 | Surface topographies for non-toxic bioadhesion control | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2015-04-28 | — | — | US | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| US-20100191216-A1 | INDICATIONS FOR LOCAL TRANSPORT OF ANAESTHETIC AGENTS BY ELECTROTRANSPORT DEVICES | KEUSCH PRESTON | 2010-07-29 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| WO-2007041476-A2 | INDICATIONS FOR LOCAL TRANSPORT OF ANAESTHETIC AGENTS BY ELECTROTRANSPORT DEVICES | VYTERIS, INC. (US) | 2007-04-12 | — | — | WO | claimed |
| US-20070078434-A1 | Indications For Local Transport of Anaesthetic Agents By Electrotransport Devices | VYTERIS, INC. (US) | 2007-04-05 | — | — | US | claimed |
| EP-1696855-A1 | DERMAL DRUG DELIVERY SYSTEM | Medpharm Limited (GB) | 2006-09-06 | — | — | EP | claimed |
| US-20060130266-A1 | Dermal drug delivery system | MEDPHARM LIMITED (GB) | 2006-06-22 | — | — | US | claimed |
| EP-1586347-A1 | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability | Vyteris, Inc. (US) | 2005-10-19 | — | — | EP | claimed |
| US-20050228336-A1 | Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability | COLLATERAL AGENTS, LLC | 2005-10-13 | — | — | US | claimed |
| WO-2005058226-A1 | DERMAL DRUG DELIVERY SYSTEM | MEDPHARM LIMITED (GB) | 2005-06-30 | — | — | WO | claimed |
| EP-4603095-A2 | IMPROVED PHARMACEUTICAL FORMULATIONS | Ferring B.V. (NL) | 2025-08-20 | — | — | EP | disclosed |
| WO-2025129358-A1 | STABLE FILM FORMULATIONS FOR HIGH LOADING OF LOW MELTING POINT ACTIVES | INTELGENX CORP. (CA) | 2025-06-26 | — | — | WO | disclosed |
| EP-0956026-A1 | PHARMACEUTICAL PREPARATIONS COMPRISED OF SALTS OF HYALURONIC ACID WITH LOCAL ANAESTHETICS | FIDIA S.p.A. (IT) | 1999-11-17 | — | — | EP | disclosed |
| WO-1998017285-A1 | PHARMACEUTICAL PREPARATIONS COMPRISED OF SALTS OF HYALURONIC ACID WITH LOCAL ANAESTHETICS | FIDIA S.P.A. (IT) | 1998-04-30 | — | — | WO | disclosed |
| US-5175172-A | Administering amino-1,2,3,4-tetrahydroacridine and derivatives for elevation of T4 lymphocytes level in patients | DIETLIN FRANCOIS (FR) | 1992-12-29 | — | — | US | disclosed |